These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 28034995)

  • 1. Effects of MRI Protocol Parameters, Preload Injection Dose, Fractionation Strategies, and Leakage Correction Algorithms on the Fidelity of Dynamic-Susceptibility Contrast MRI Estimates of Relative Cerebral Blood Volume in Gliomas.
    Leu K; Boxerman JL; Ellingson BM
    AJNR Am J Neuroradiol; 2017 Mar; 38(3):478-484. PubMed ID: 28034995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moving Toward a Consensus DSC-MRI Protocol: Validation of a Low-Flip Angle Single-Dose Option as a Reference Standard for Brain Tumors.
    Schmainda KM; Prah MA; Hu LS; Quarles CC; Semmineh N; Rand SD; Connelly JM; Anderies B; Zhou Y; Liu Y; Logan B; Stokes A; Baird G; Boxerman JL
    AJNR Am J Neuroradiol; 2019 Apr; 40(4):626-633. PubMed ID: 30923088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved Leakage Correction for Single-Echo Dynamic Susceptibility Contrast Perfusion MRI Estimates of Relative Cerebral Blood Volume in High-Grade Gliomas by Accounting for Bidirectional Contrast Agent Exchange.
    Leu K; Boxerman JL; Cloughesy TF; Lai A; Nghiemphu PL; Liau LM; Pope WB; Ellingson BM
    AJNR Am J Neuroradiol; 2016 Aug; 37(8):1440-6. PubMed ID: 27079371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Software Modeling on the Accuracy of Perfusion MRI in Glioma.
    Hu LS; Kelm Z; Korfiatis P; Dueck AC; Elrod C; Ellingson BM; Kaufmann TJ; Eschbacher JM; Karis JP; Smith K; Nakaji P; Brinkman D; Pafundi D; Baxter LC; Erickson BJ
    AJNR Am J Neuroradiol; 2015 Dec; 36(12):2242-9. PubMed ID: 26359151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of a T1 and T2* leakage correction method based on multiecho dynamic susceptibility contrast MRI using MION as a reference standard.
    Stokes AM; Semmineh N; Quarles CC
    Magn Reson Med; 2016 Aug; 76(2):613-25. PubMed ID: 26362714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of Acquisition and Analysis Methods for Clinical Dynamic Susceptibility Contrast MRI Using a Population-Based Digital Reference Object.
    Semmineh NB; Bell LC; Stokes AM; Hu LS; Boxerman JL; Quarles CC
    AJNR Am J Neuroradiol; 2018 Nov; 39(11):1981-1988. PubMed ID: 30309842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consistency of normalized cerebral blood volume values in glioblastoma using different leakage correction algorithms on dynamic susceptibility contrast magnetic resonance imaging data without and with preload.
    Hedderich D; Kluge A; Pyka T; Zimmer C; Kirschke JS; Wiestler B; Preibisch C
    J Neuroradiol; 2019 Feb; 46(1):44-51. PubMed ID: 29753641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of Percentage Signal Recovery and Baseline Signal in DSC-MRI Optimized for Relative CBV Measurement for Differentiating Glioblastoma, Lymphoma, Metastasis, and Meningioma.
    Lee MD; Baird GL; Bell LC; Quarles CC; Boxerman JL
    AJNR Am J Neuroradiol; 2019 Sep; 40(9):1445-1450. PubMed ID: 31371360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic assessment of multi-echo dynamic susceptibility contrast MRI using a digital reference object.
    Stokes AM; Semmineh NB; Nespodzany A; Bell LC; Quarles CC
    Magn Reson Med; 2020 Jan; 83(1):109-123. PubMed ID: 31400035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of pseudo-continuous arterial spin labelling and dynamic susceptibility contrast MRI with and without contrast agent leakage correction in paediatric brain tumours.
    Novak J; Withey SB; Lateef S; MacPherson L; Pinkey B; Peet AC
    Br J Radiol; 2019 Feb; 92(1094):20170872. PubMed ID: 30358415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors.
    Paulson ES; Schmainda KM
    Radiology; 2008 Nov; 249(2):601-13. PubMed ID: 18780827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomas.
    Boxerman JL; Quarles CC; Hu LS; Erickson BJ; Gerstner ER; Smits M; Kaufmann TJ; Barboriak DP; Huang RH; Wick W; Weller M; Galanis E; Kalpathy-Cramer J; Shankar L; Jacobs P; Chung C; van den Bent MJ; Chang S; Al Yung WK; Cloughesy TF; Wen PY; Gilbert MR; Rosen BR; Ellingson BM; Schmainda KM;
    Neuro Oncol; 2020 Sep; 22(9):1262-1275. PubMed ID: 32516388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of DSC MRI Echo Times for CBV Measurements Using Error Analysis in a Pilot Study of High-Grade Gliomas.
    Bell LC; Does MD; Stokes AM; Baxter LC; Schmainda KM; Dueck AC; Quarles CC
    AJNR Am J Neuroradiol; 2017 Sep; 38(9):1710-1715. PubMed ID: 28684456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective comparative diagnostic accuracy evaluation of dynamic contrast-enhanced (DCE) vs. dynamic susceptibility contrast (DSC) MR perfusion in differentiating tumor recurrence from radiation necrosis in treated high-grade gliomas.
    Zakhari N; Taccone MS; Torres CH; Chakraborty S; Sinclair J; Woulfe J; Jansen GH; Cron GO; Thornhill RE; McInnes MDF; Nguyen TB
    J Magn Reson Imaging; 2019 Aug; 50(2):573-582. PubMed ID: 30614146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multisite Concordance of DSC-MRI Analysis for Brain Tumors: Results of a National Cancer Institute Quantitative Imaging Network Collaborative Project.
    Schmainda KM; Prah MA; Rand SD; Liu Y; Logan B; Muzi M; Rane SD; Da X; Yen YF; Kalpathy-Cramer J; Chenevert TL; Hoff B; Ross B; Cao Y; Aryal MP; Erickson B; Korfiatis P; Dondlinger T; Bell L; Hu L; Kinahan PE; Quarles CC
    AJNR Am J Neuroradiol; 2018 Jun; 39(6):1008-1016. PubMed ID: 29794239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of Tumor Immunohistochemistry with Dynamic Contrast-Enhanced and DSC-MRI Parameters in Patients with Gliomas.
    Nguyen TB; Cron GO; Bezzina K; Perdrizet K; Torres CH; Chakraborty S; Woulfe J; Jansen GH; Thornhill RE; Zanette B; Cameron IG
    AJNR Am J Neuroradiol; 2016 Dec; 37(12):2217-2223. PubMed ID: 27585700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous perfusion and permeability assessments using multiband multi-echo EPI (M2-EPI) in brain tumors.
    Wu J; Saindane AM; Zhong X; Qiu D
    Magn Reson Med; 2019 Mar; 81(3):1755-1768. PubMed ID: 30298595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of pulse sequence parameters and contrast agent dose on percentage signal recovery in DSC-MRI: implications for clinical applications.
    Boxerman JL; Paulson ES; Prah MA; Schmainda KM
    AJNR Am J Neuroradiol; 2013 Jul; 34(7):1364-9. PubMed ID: 23413249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of three leakage-correction methods for DSC-based measurement of relative cerebral blood volume with respect to heterogeneity in human gliomas.
    Kluge A; Lukas M; Toth V; Pyka T; Zimmer C; Preibisch C
    Magn Reson Imaging; 2016 May; 34(4):410-21. PubMed ID: 26708034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bidirectional Contrast agent leakage correction of dynamic susceptibility contrast (DSC)-MRI improves cerebral blood volume estimation and survival prediction in recurrent glioblastoma treated with bevacizumab.
    Leu K; Boxerman JL; Lai A; Nghiemphu PL; Pope WB; Cloughesy TF; Ellingson BM
    J Magn Reson Imaging; 2016 Nov; 44(5):1229-1237. PubMed ID: 26971534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.